Literature DB >> 7896943

The mast cell and mast cell disease.

J Longley1, T P Duffy, S Kohn.   

Abstract

Mast cell disease or mastocytosis is a heterogeneous group of clinical disorders characterized by the proliferation and accumulation of mast cells in a variety of tissues, most often the skin. The signs and symptoms of mast cell disease are varied, dependent on the localization of mast cells in different organs and the local and systemic effects of mediators released from these cells. Although mast cell disease is most commonly identified in the skin, involvement of the skeletal, hematopoietic, gastrointestinal, cardiopulmonary, and central nervous systems may be seen. Clinical management of mastocytosis depends most heavily on knowledge of the diverse effects of mast cell mediators on various tissues and organs, the stimuli that can cause their release, and the different methods available for blocking the effects of these mediators.

Entities:  

Mesh:

Year:  1995        PMID: 7896943     DOI: 10.1016/0190-9622(95)90336-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

1.  Paediatric mastocytosis.

Authors:  M C Carter; D D Metcalfe
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

2.  Chymase cleavage of stem cell factor yields a bioactive, soluble product.

Authors:  B J Longley; L Tyrrell; Y Ma; D A Williams; R Halaban; K Langley; H S Lu; N M Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Red-brown skin lesions and pruritus.

Authors:  J C Cather; M A Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-07

4.  Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.

Authors:  X Piao; R Paulson; P van der Geer; T Pawson; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 5.  Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Authors:  Mariana Castells; Dean D Metcalfe; Luis Escribano
Journal:  Am J Clin Dermatol       Date:  2011-08-01       Impact factor: 7.403

6.  Diffuse cutaneous mastocytosis with generalized bullae.

Authors:  Eui Hyung Lee; Mi Ri Kim; Tae Won Kang; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

7.  Immunomodulation of afferent neurons in guinea-pig isolated airway.

Authors:  M M Riccio; A C Myers; B J Undem
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

8.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.

Authors:  B J Longley; D D Metcalfe; M Tharp; X Wang; L Tyrrell; S Z Lu; D Heitjan; Y Ma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats.

Authors:  Miguel-Angel Llamas; María-Angeles Aller; Domingo Marquina; María-Paz Nava; Jaime Arias
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

10.  Cutaneous mastocytosis. Getting beneath the skin of the issue: a case report.

Authors:  Parag M Tamhankar; Jyoti Suvarna; Chandrahas T Deshmukh
Journal:  Cases J       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.